Diaceutics PLC (DXRX)

Over the last 90 days, Diaceutics PLC has seen insider buying activity totaling £998,348. Three executives, including the Chief Data Officer, Chief Finance Officer, and Chief Precision Medicine Officer, made purchases in March and April 2026. No sales were recorded by insiders during this period. The stock has experienced a 3.7% decrease in price over the past 90 days.
Stock chart
Ticker: DXRX Exchange: LSE


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Nick Roberts
Chief Finance Officer
1 purchase — total 150 GBP
Buy 30 Apr 2026
Value £4,014,016.82 | Price 359.78 | Shares 78,034
Buy 30 Apr 2026
Value £651,291.54 | Price 16.97 | Shares 82,269
Buy 30 Mar 2026
Value £148.90 | Price 1.49 | Shares 100
Buy 30 Mar 2026
Value £148.90 | Price 1.49 | Shares 100
Buy 30 Mar 2026
Value £148.90 | Price 1.49 | Shares 100
Buy 22 May 2024
Value £51,470.93 | Price 1.29 | Shares 39,934
Sale 28 Mar 2024
Value £765,000.00 | Price 1.02 | Shares 750,000
Sale 28 Mar 2024
Value £765,000.00 | Price 1.02 | Shares 750,000
Buy 6 Mar 2024
Value £33,060.54 | Price 0.99 | Shares 33,564
Buy 5 Jun 2023
Value £19,948.29 | Price 0.92 | Shares 21,742
Sale 4 May 2023
Value £49,000.00 | Price 0.98 | Shares 50,000
Sale 28 Apr 2023
Value £3,060.00 | Price 1.02 | Shares 3,000
Sale 21 Apr 2023
Value £104,500.00 | Price 1.05 | Shares 100,000
Sale 6 Apr 2022
Value £137,200.00 | Price 0.98 | Shares 140,000
Sale 6 Apr 2022
Value £60,600.00 | Price 1.01 | Shares 60,000
Buy 6 Apr 2022
Value £20,200.00 | Price 1.01 | Shares 20,000
Buy 6 Apr 2022
Value £5,100.00 | Price 1.02 | Shares 5,000
Buy 6 Apr 2022
Value £15,150.00 | Price 1.01 | Shares 15,000
Buy 5 Apr 2022
Value £39,766.69 | Price 1.02 | Shares 39,179
Buy 27 Sep 2021
Value £19,758.00 | Price 1.11 | Shares 17,800
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-05 2026-04-30 B Purchase

Chief Finance Officer

Officer
78,034
359.78
£4,014,017
78,034 359.78 £4,014,017
2026-05-05 2026-04-30 B Purchase

Chief Data Officer

Officer
82,269
16.97
£651,292
82,269 16.97 £651,292
2026-04-01 2026-03-30 B Purchase

Chief Finance Officer

Officer
74,045
320.85
£1,442,541
74,045 320.85 £1,442,541
2026-04-01 2026-03-30 B Purchase

Chief Data Officer

Officer
100
1.49
£149
100 1.49 £149
2026-04-01 2026-03-30 B Purchase

Chief Precision Medicine Officer

Officer
100
1.49
£149
100 1.49 £149
2024-05-23 2024-05-22 B Purchase

Non-Executive Director

Executive Director
39,934
1.29
£51,471
39,934 1.29 £51,471
2024-04-02 2024-03-28 S Sale

PCA

750,000
1.02
£765,000
750,000 1.02 £765,000
2024-04-02 2024-03-28 S Sale

Executive Director

Executive Director
750,000
1.02
£765,000
750,000 1.02 £765,000
2024-03-07 2024-03-06 B Purchase

Non-Executive Director

Executive Director
33,564
0.99
£33,061
33,564 0.99 £33,061
2023-06-06 2023-06-05 B Purchase

CFO

Officer
21,742
0.92
£19,948
21,742 0.92 £19,948
2023-05-11 2023-05-04 S Sale

Chief Commercial Officer

Officer
50,000
0.98
£49,000
50,000 0.98 £49,000
2023-05-04 2023-04-28 S Sale

Chief Commercial Officer

Officer
3,000
1.02
£3,060
3,000 1.02 £3,060
2023-04-26 2023-04-21 S Sale

Chief Commercial Officer

Officer
100,000
1.05
£104,500
100,000 1.05 £104,500
2022-04-07 2022-04-06 S Sale

PDMR

140,000
0.98
£137,200
140,000 0.98 £137,200
2022-04-07 2022-04-06 S Sale

PDMR

60,000
1.01
£60,600
60,000 1.01 £60,600
2022-04-07 2022-04-06 B Purchase

Non-Executive Director

Executive Director
20,000
1.01
£20,200
20,000 1.01 £20,200
2022-04-07 2022-04-06 B Purchase

Chair

Director
5,000
1.02
£5,100
5,000 1.02 £5,100
2022-04-07 2022-04-06 B Purchase

Chair

Director
15,000
1.01
£15,150
15,000 1.01 £15,150
2022-04-07 2022-04-05 B Purchase

CFO

Officer
39,179
1.02
£39,767
39,179 1.02 £39,767
2021-09-28 2021-09-27 B Purchase

Chair

Director
17,800
1.11
£19,758
17,800 1.11 £19,758